These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 11291079)
21. Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma. Kulke MH; Odze RD; Thakore KS; Thomas G; Wang H; Loda M; Eng C Br J Cancer; 2001 Mar; 84(6):748-53. PubMed ID: 11259087 [TBL] [Abstract][Full Text] [Related]
22. Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles. Kurose K; Bando K; Fukino K; Sugisaki Y; Araki T; Emi M Jpn J Cancer Res; 1998 Aug; 89(8):842-8. PubMed ID: 9765621 [TBL] [Abstract][Full Text] [Related]
23. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052 [TBL] [Abstract][Full Text] [Related]
24. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma. Feilotter HE; Coulon V; McVeigh JL; Boag AH; Dorion-Bonnet F; Duboué B; Latham WC; Eng C; Mulligan LM; Longy M Br J Cancer; 1999 Feb; 79(5-6):718-23. PubMed ID: 10070859 [TBL] [Abstract][Full Text] [Related]
25. Lack of somatic mutation in the PTEN gene in squamous cell carcinomas of human skin. Kubo Y; Urano Y; Hida Y; Arase S J Dermatol Sci; 1999 Apr; 19(3):199-201. PubMed ID: 10215192 [TBL] [Abstract][Full Text] [Related]
26. PTEN/MMAC1/TEP1 involvement in primary prostate cancers. Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R Oncogene; 1998 Jun; 16(22):2879-83. PubMed ID: 9671408 [TBL] [Abstract][Full Text] [Related]
27. CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine (Merkel cell) carcinoma of the skin. Cook AL; Pollock PM; Welch J; Walsh MD; Bowman RV; Baumann KC; Hayward NK; Leonard JH Int J Cancer; 2001 Aug; 93(3):361-7. PubMed ID: 11433400 [TBL] [Abstract][Full Text] [Related]
28. Common genetic changes between endometriosis and ovarian cancer. Obata K; Hoshiai H Gynecol Obstet Invest; 2000; 50 Suppl 1():39-43. PubMed ID: 11093060 [TBL] [Abstract][Full Text] [Related]
29. Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Perren A; Komminoth P; Saremaslani P; Matter C; Feurer S; Lees JA; Heitz PU; Eng C Am J Pathol; 2000 Oct; 157(4):1097-103. PubMed ID: 11021813 [TBL] [Abstract][Full Text] [Related]
30. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers. Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402 [TBL] [Abstract][Full Text] [Related]
31. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer. Su TH; Chang JG; Perng LI; Chang CP; Wei HJ; Wang NM; Tsai CH Gynecol Oncol; 2000 Feb; 76(2):193-9. PubMed ID: 10637069 [TBL] [Abstract][Full Text] [Related]
32. The PTEN tumour suppressor gene and malignant melanoma. Böni R; Vortmeyer AO; Burg G; Hofbauer G; Zhuang Z Melanoma Res; 1998 Aug; 8(4):300-2. PubMed ID: 9764804 [TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719 [TBL] [Abstract][Full Text] [Related]
34. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma. Yeh KT; Chang JG; Chen YJ; Chen ST; Yu SY; Shih MC; Perng LI; Wang JC; Tsai M; Chang CP Cancer Invest; 2000; 18(2):123-9. PubMed ID: 10705874 [TBL] [Abstract][Full Text] [Related]
35. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750 [TBL] [Abstract][Full Text] [Related]
36. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Zhou XP; Gimm O; Hampel H; Niemann T; Walker MJ; Eng C Am J Pathol; 2000 Oct; 157(4):1123-8. PubMed ID: 11021816 [TBL] [Abstract][Full Text] [Related]
37. Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies. Birck A; Ahrenkiel V; Zeuthen J; Hou-Jensen K; Guldberg P J Invest Dermatol; 2000 Feb; 114(2):277-80. PubMed ID: 10651986 [TBL] [Abstract][Full Text] [Related]
38. Intratumoral heterogeneity in microsatellite alterations in BRCA1 and PTEN regions in sporadic colorectal cancer. Garcia JM; Rodriguez R; Silva J; Muñoz C; Dominguez G; Silva JM; Carcereny E; Provencio M; España P; Bonilla F Ann Surg Oncol; 2003 Oct; 10(8):876-81. PubMed ID: 14527905 [TBL] [Abstract][Full Text] [Related]
39. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766 [TBL] [Abstract][Full Text] [Related]
40. Loss of heterozygosity on chromosome 10q23 and mutation of the phosphatase and tensin homolog deleted from chromosome 10 tumor suppressor gene in Korean hepatocellular carcinoma patients. Bae JJ; Rho JW; Lee TJ; Yun SS; Kim HJ; Choi JH; Jeong D; Jang BC; Lee TY Oncol Rep; 2007 Oct; 18(4):1007-13. PubMed ID: 17786367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]